Findings from the researchers’ study of the safety and efficacy of the vaccine were published this week in a peer-reviewed journal. Phase 2 trials are underway.
In celebration of World Immunization Week, McMaster is proud to highlight our storied legacy in vaccine research, development, and innovation spanning over 50 years.
The AeroVax study will test needle-free vaccines that proved more effective than traditional injected vaccines in pre-clinical studies and the Phase 1 trial.
McMaster logo
McMaster logo
